Date Filed | Type | Description |
08/08/2023 |
4
| Braunstein Scott (CHAIRMAN AND CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS, INC.
Txns:
| Sold 6,413 shares
@ $9.55, valued at
$61.2k
Sold 30 shares
@ $8.94, valued at
$268.2 |
|
02/23/2023 |
4
| Braunstein Scott (Director) has filed a Form 4 on Caribou Biosciences, Inc.
Txns:
| Granted 21,500 options to buy
@ $6.12, valued at
$131.6k
|
|
01/30/2023 |
4
| Braunstein Scott (CHAIRMAN AND CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS, INC.
Txns:
| Granted 80,000 shares
@ $0 Granted 360,000 options to buy
@ $5.94, valued at
$2.1M
|
|
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2021 |
3
| Braunstein Scott (Director) has filed a Form 3 on Caribou Biosciences, Inc. |
07/19/2021 |
4
| Braunstein Scott (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns:
| Disposed/sold 13,171 options to buy
@ $33.57, valued at
$442.2k
Disposed/sold 26,342 options to buy
@ $10.81, valued at
$284.8k
Disposed/sold 13,171 options to buy
@ $37.52, valued at
$494.2k
|
|
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2020 |
4
| Braunstein Scott (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns:
| Granted 9,000 options to buy
@ $35, valued at
$315k
|
|
06/11/2020 |
4/A
| Braunstein Scott (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns:
| Granted 2,861 options to buy
@ $9.18, valued at
$26.3k
Granted 16,214 options to buy
@ $9.18, valued at
$148.8k
Granted 15,641 options to buy
@ $9.18, valued at
$143.6k
|
|
06/08/2020 |
4
| Braunstein Scott (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns:
| Granted 13,171 options to buy
@ $37.52, valued at
$494.2k
|
|
05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2020 |
4
| Braunstein Scott (Director) has filed a Form 4 on ArTara Therapeutics, Inc.
Txns:
| Granted 26,500 shares
@ $0 Granted 9,537 options to buy
@ $9.18, valued at
$87.5k
Granted 2,861 options to buy
@ $9.18, valued at
$26.3k
Granted 6,676 options to buy
@ $9.18, valued at
$61.3k
Granted 15,737 options to buy
@ $9.18, valued at
$144.5k
|
|
01/13/2020 |
3
| Braunstein Scott (Director) has filed a Form 3 on ArTara Therapeutics, Inc. |
01/10/2020 |
4
| Braunstein Scott (CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS INC
Txns:
| Granted 1,800,000 options to buy
@ $2.07, valued at
$3.7M
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2019 |
4
| Braunstein Scott (CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS INC
Txns:
| Bought 100,000 shares
@ $1.25, valued at
$125k
|
|
08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2019 |
4
| Braunstein Scott (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns:
| Granted 4,967 shares
@ $0 |
|
05/16/2019 |
4
| Braunstein Scott (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 30,000 options to buy
@ $1.34, valued at
$40.2k
|
|
02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/02/2019 |
4
| Braunstein Scott (Director) has filed a Form 4 on ZIOPHARM ONCOLOGY INC
Txns:
| Granted 126,700 options to buy
@ $1.87, valued at
$236.9k
|
|
10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/20/2018 |
4
| Braunstein Scott (Director) has filed a Form 4 on ZIOPHARM ONCOLOGY INC
Txns:
| Granted 50,000 options to buy
@ $3, valued at
$150k
|
|
09/20/2018 |
3
| Braunstein Scott (Director) has filed a Form 3 on ZIOPHARM ONCOLOGY INC |
09/20/2018 |
3
| Braunstein Scott (Director) has filed a Form 3 on MARINUS PHARMACEUTICALS INC |
05/25/2018 |
4
| Braunstein Scott (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns:
| Granted 10,100 options to buy
@ $38.32, valued at
$387k
|
|
|